Editorial: Risk Factors and Outcome Predicating Biomarker of Neurodegenerative Diseases.
作者信息
Hu Chaur-Jong, Octave Jean-Noël
机构信息
Department of Neurology, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.
Department of Neurology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
出版信息
Front Neurol. 2019 Feb 4;10:45. doi: 10.3389/fneur.2019.00045. eCollection 2019.
Abstract
摘要
相似文献
1
Editorial: Risk Factors and Outcome Predicating Biomarker of Neurodegenerative Diseases.
Front Neurol. 2019 Feb 4;10:45. doi: 10.3389/fneur.2019.00045. eCollection 2019.
2
New drug treatments show neuroprotective effects in Alzheimer's and Parkinson's diseases.新的药物治疗在阿尔茨海默病和帕金森病中显示出神经保护作用。
Neural Regen Res. 2014 Nov 1;9(21):1870-3. doi: 10.4103/1673-5374.145342.
3
Understanding Epigenetic Alterations in Alzheimer's and Parkinson's Disease: Towards Targeted Biomarkers and Therapies.了解阿尔茨海默病和帕金森病中的表观遗传学改变：迈向靶向生物标志物和疗法。
Curr Pharm Des. 2017;23(5):839-857. doi: 10.2174/1381612823666170124121140.
4
Glycation in Parkinson's disease and Alzheimer's disease.帕金森病和阿尔茨海默病中的糖基化作用。
Mov Disord. 2016 Jun;31(6):782-90. doi: 10.1002/mds.26566. Epub 2016 Mar 4.
5
Loss of gait control assessed by cognitive-motor dual-tasks: pros and cons in detecting people at risk of developing Alzheimer's and Parkinson's diseases.认知-运动双重任务评估步态控制丧失：在检测有发展为阿尔茨海默病和帕金森病风险的人群方面的优缺点。
Geroscience. 2017 Jun;39(3):305-329. doi: 10.1007/s11357-017-9977-7. Epub 2017 May 27.
6
Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease.血浆表皮生长因子与帕金森病和阿尔茨海默病患者认知能力下降的关系。
Ann Clin Transl Neurol. 2016 Mar 29;3(5):346-55. doi: 10.1002/acn3.299. eCollection 2016 May.
7
Occupational Exposures and Neurodegenerative Diseases-A Systematic Literature Review and Meta-Analyses.职业暴露与神经退行性疾病——系统文献综述和荟萃分析。
Int J Environ Res Public Health. 2019 Jan 26;16(3):337. doi: 10.3390/ijerph16030337.
8
Editorial: Unraveling Neuroprotective and Neurodegenerative Signals in Neurodegeneration.社论：解析神经退行性变中的神经保护和神经退行性信号
Front Neurosci. 2016 Jul 13;10:328. doi: 10.3389/fnins.2016.00328. eCollection 2016.
9
Editorial: Mitochondrial Dysfunction and Neurodegeneration.社论：线粒体功能障碍与神经退行性变
Front Neurosci. 2019 Dec 18;13:1372. doi: 10.3389/fnins.2019.01372. eCollection 2019.
10
Editorial: Metals and neurodegeneration: restoring the balance.社论：金属与神经退行性变：恢复平衡
Front Aging Neurosci. 2015 Jul 2;7:127. doi: 10.3389/fnagi.2015.00127. eCollection 2015.
引用本文的文献
1
The Effects of (Burm.F.) Wall. Ex Nees and Andrographolide on Neuroinflammation in the Treatment of Neurodegenerative Diseases.穿心莲（Burm.F.）Wall. Ex Nees 和穿心莲内酯对神经退行性疾病神经炎症的影响。
Nutrients. 2023 Aug 2;15(15):3428. doi: 10.3390/nu15153428.
本文引用的文献
1
Diabetes mellitus and Parkinson disease.糖尿病与帕金森病。
Neurology. 2018 May 8;90(19):e1654-e1662. doi: 10.1212/WNL.0000000000005475. Epub 2018 Apr 6.
2
The Risk of Incident Mild Cognitive Impairment and Progression to Dementia Considering Mild Cognitive Impairment Subtypes.考虑轻度认知障碍亚型的新发轻度认知障碍及进展为痴呆症的风险
Dement Geriatr Cogn Dis Extra. 2017 Feb 2;7(1):15-29. doi: 10.1159/000452486. eCollection 2017 Jan-Apr.
3
Parkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trials.特发性快速眼动睡眠行为障碍中的帕金森病风险：为神经保护试验做准备。
Neurology. 2015 Mar 17;84(11):1104-13. doi: 10.1212/WNL.0000000000001364. Epub 2015 Feb 13.
4
Prerequisites to launch neuroprotective trials in Parkinson's disease: an industry perspective.启动帕金森病神经保护试验的先决条件：行业视角。
Mov Disord. 2012 Apr 15;27(5):651-5. doi: 10.1002/mds.25017.
5
Ageing, neurodegeneration and Parkinson's disease.衰老、神经退行性变与帕金森病。
Age Ageing. 2010 Mar;39(2):156-61. doi: 10.1093/ageing/afp223. Epub 2010 Jan 5.
6
Contribution of vascular risk factors to the progression in Alzheimer disease.血管危险因素在阿尔茨海默病进展中的作用。
Arch Neurol. 2009 Mar;66(3):343-8. doi: 10.1001/archneur.66.3.343.
7
Mild cognitive impairment in the elderly: predictors of dementia.老年人的轻度认知障碍：痴呆症的预测因素。
Neurology. 1991 Jul;41(7):1006-9. doi: 10.1212/wnl.41.7.1006.
Zotero 插件